Results per Page:
Assessing HER2 expression in metastatic prostate and urothelial cancers
From Dr. Raychaudhuri, Dr. Haffner and colleagues, Clinical Research Division
Colorado patient chooses proton therapy following prostate cancer surgery
With no local proton therapy facilities, patient turned to Fred Hutch for its research and reputation
Probing the predictive power of precision diagnostics
From the Etzioni Group, Public Health Sciences Division and the Cancer Consortium
Más allá de las cifras: la confianza, la voz y la lucha contra el cáncer de próstata
Del grupo de investigación Nyame, Departamento de Ciencias de la Salud Pública.
Lived experience matters: patient engagement improves cancer care, research
Nearly 15 years in, Fred Hutch Patient and Family Engagement Program continues to inform care, expands to match advocates with researchers
Dr. Yeon Soo Kim receives NIH Pathway to Independence Award
Hsieh Lab postdoctoral fellow studies how advanced prostate cancer evades therapy by altering the way RNA builds proteins
Testing for hereditary cancers can be a lifesaver
Some people aren’t ready yet, while others believe ‘forewarned is forearmed’ when it comes to cancer-causing genetic variants
Whole-body MRI and cancer screening
A perspective from radiologists at Fred Hutch Cancer Center and UW Medicine
Inside every patient, a universe
From the Haffner Lab, Human Biology Division
Conditionally activated immunotherapies alleviate cancer treatment toxicity
From the Fong Lab, Translational Sciences and Therapeutics
Starting the year smarter
How patients, providers, researchers and others stay informed amid a deluge of data and information
Cigarettes or vapes, pick your poison
From the Fong Lab, Translational Sciences & Therapeutics Division
Travel writer takes an unexpected cancer journey
Writer and TV host Rick Steves deals with a prostate cancer diagnosis and offers hope to others
Polygenic risk scores and prostate cancer
New research shows genetic risk scores could help distinguish who can cut back on ‘active surveillance’
10 years in, HICOR’s efforts boost cancer care’s value
Fred Hutch’s Value in Cancer Care Initiative celebrates a decade of data and crucial collaborations between providers, payers and patients
Finding a new way to break the supply chain fueling advanced prostate cancer
Fred Hutch researcher wins a $1M grant for a London-Seattle collaboration to find new therapies for drug-resistant prostate cancer